WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

Legislation would have cut Chinese businesses off from US WuXi executives say the companies continue to sign new clients WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 ...

At the recent JP Morgan Healthcare Conference 2025, WuXi Biologics’ CEO Chris Chen said the company continues to sign foreign clients and investing in the US, despite political headwinds related to ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other ... ET Despite challenges in the CDMO industry, Samsung Biologics is "well positioned to kick-start a new ...

A Vision for the Future Wuxi’s UNESCO application is not merely a recognition of its past; it’s a commitment to its future. The city plans to expand its cultural infrastructure, invest in creative ...

A Vision for the Future Wuxi’s UNESCO application is not merely a recognition of its past; it’s a commitment to its future. The city plans to expand its cultural infrastructure, invest in ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

SHANGHAI and SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Image credit: Shutterstock / CI Photos. US-based Candid Therapeutics has signed another T-cell engager (TCE) partnership, this time with Chinese biotech WuXi Biologics for the global rights to a ...